Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Gene Therapy Development
West Pharmaceutical Solutions: Gene Therapy and Daikyo Crystal Zenith® Vials Case Study
Gene Therapy Development
West Pharmaceutical Solutions: Packaging Containment Solutions for Gene Therapy Products
Cell Therapy Analytics
Glyn Stacey, Chief Executive at SSCBio leads a discussion on the current landscape of ‘Cell Therapy Analytics'.
Manufacturing & Bioprocessing
Upstream Bioprocessing
Amir Reza Goudarzi, former Engineering Head of UCB in Brussels, leads a discussion on ‘Upstream Bioprocessing.'
Immunotherapy (Non-Oncology)
Treating Autoimmune Diseases: Past, Present, and Future
Bringing together the experts to discuss the timeline of autoimmune disease therapeutics.
Drug Discovery & Development
Targeting Solid Tumours With TCR Guided NK Cells
Video Interview | Namir Hassan, CEO at Zelluna Immunotherapy
3D Cell Culture
3D Model Development
Oxford Global's Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our April Discussion Group addressing ‘3D Model Development' brought together an exclusive panel of key opinion leaders to address the market's growth and future directions.
Immuno-Oncology
Better IO Clinical Trials with ImmunoPET Imaging
Ian A Wilson of ImaginAb delivers the presentation ‘The Value of In Vivo Imaging on the Clinical Development of IO Drugs’ at Oxford Global’s discussion group.
